Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
Metin Özdemirli, Thomas Loughney, Emre Deniz, Joeffrey Chahine, Maher Albitar, Stefania Pittaluga, Sam Sadigh, Philippe Armand, Aykut Uren, Kenneth C. Anderson
Abstract
gene. In addition, numerous genetic alterations that may have contributed to malignant transformation were identified in the tumor sample. (Funded by MedStar Georgetown University Hospital.).
Topics & Concepts
CAR T-cell therapyLymphomaT cellT-cell lymphomaMedicineCancer researchCell therapyChimeric antigen receptorCellImmunologyBiologyImmune systemGeneticsCAR-T cell therapy researchLymphoma Diagnosis and TreatmentVirus-based gene therapy research